Federal prosecutors are considering criminal charges against former executives of a Bay Area pharmaceutical company for the off-label marketing of an osteoporosis drug. The former CEO has turned to MoFo's James Brosnahan for help.
Pharma Execs Facing Probe
January 25, 2008
This article requires premium access
This article requires premium access to The Recorder. Please sign in or subscribe to read the full text.